地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:13212737804
邮箱:sales@amyjet.com

艾美捷科技代理ImmunoStep品牌。
ImmunoStep是一家专注于流式细胞术和免疫学研究的生物技术公司,主要提供高质量的试剂和工具,支持免疫表型分析、细胞功能研究和临床诊断。ImmunoStep公司的产品与服务包括:
(1)流式细胞术试剂:
抗体:提供多种荧光标记的单克隆抗体,适用于人、小鼠、大鼠等物种。
染色缓冲液:优化细胞染色过程。
细胞活力染料:用于区分活细胞和死细胞。
(2)试剂盒:
免疫表型分析试剂盒:用于快速、多参数分析免疫细胞亚群。
细胞因子检测试剂盒:用于检测细胞内或分泌的细胞因子。
(3)定制服务:
抗体标记:根据客户需求定制荧光标记抗体。
面板设计:帮助客户设计多色流式细胞术实验面板。
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理ImmunoStep品牌"> 艾美捷科技代理ImmunoStep品牌
成立27年来,PBL Assay Science一直协助工业界、学术界、政府研究人员开发检测方法和解决蛋白定量问题。PBL Assay Science的产品包括高品质、高灵敏度的ELISA试剂盒、干扰素蛋白和抗体等,此外PBL Assay Science还提供超灵敏细胞因子检测服务等。
Now entering our 27th year, PBL Assay Science works hand in hand with industry, academic, and government researchers to help solve difficult assay development and protein quantification problems. Known as a trusted source for high quality, high sensitivity ELISAs as well as interferon proteins and antibodies, PBL has expanded our assay services capabilities, including ultrasensitive cytokine detection services, and increased our human cell-expressed cytokine and growth factor offerings.
PBL Assay Science的主要产品包括:
(1)Assay Kits(ELISAs;Multiplex Assays;Cell-Based Assays)
(2)Proteins(Interferons,Cytokines and Growth Factors,Interferon Decoy Receptor)
(3)Antibodies(Monoclonal Antibodies (MAbs);Polyclonal Antibodies (PAbs))
(4)Assay Services(Quantitative Immunoassays;Cell-Based Services;Reagent Development)
| Assay Kits产品列表 |
| 品名 | 货号 | 规格 |
| iLite Human Type I IFN Responsive Cells | 51100 | 2.5 ml/vial |
| Human IFN-Alpha Multi-Subtype ELISA Kit (Serum, Plasma, TCM) | 41110-1 | 1 x 96-well plate |
| Human IFN-Alpha Multi-Subtype ELISA Kit (Serum, Plasma, TCM) | 41110-2 | 5 x 96-well plates |
| Human IFN-Alpha Multi-Subtype ELISA Kit (TCM) | 41105-1 | 1 x 96-well plate |
| Human IFN-Alpha Multi-Subtype ELISA Kit (TCM) | 41105-2 | 5 x 96-well plates |
| Human IFN-Alpha ELISA Kit (TCM) | 41100-1 | 1 x 96-well plate |
| Human IFN-Alpha ELISA Kit (TCM) | 41100-2 | 5 x 96-well plates |
| Human IFN-Alpha All Subtype ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 41115-1 | 1 x 96-well plate |
| Human IFN-Alpha All Subtype ELISA Kit, High Sensitivity (TCM) | 41135-1 | 1 x 96-well plate |
| Human IFN-Beta ELISA Kit | 41410-1 | 1 x 96-well plate |
| Human IFN-Beta ELISA Kit | 41410-2 | 5 x 96-well plates |
| Human IFN-Beta TCM ELISA, High Sensitivity | 41435-1 | 1 x 96-well plate |
| Human IFN-Beta ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 41415-1 | 1 x 96-well plate |
| Human IFNGR1 ELISA Kit (Serum, Plasma, Cell Lysate, TCM) | 41580 | 1 x 96-well plate |
| DIY Human IFN-Lambda 1/2/3 (IL-29/28A/28B) ELISA (TCM) | 61840-1 | Materials for 15 x 96-wells |
| DIY Human IFN-Lambda 2/3 (IL-28A/B) ELISA (TCM) | 61830-1 | Materials for 15 x 96-wells |
| Mouse IFN-Alpha All Subtype ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 42115-1 | 1 x 96-well plate |
| Mouse IFN-Alpha ELISA Kit (TCM) | 42120-1 | 1 x 96-well plate |
| Mouse IFN-Alpha ELISA Kit (TCM) | 42120-2 | 5 x 96-well plates |
| Mouse IFN-Beta ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 42410-1 | 1 x 96-well plate |
| Mouse IFN-Beta ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 42410-2 | 5 x 96-well plates |
| Mouse IFN-Beta ELISA Kit (TCM, Serum) | 42400-1 | 1 x 96-well plate |
| Mouse IFN-Beta ELISA Kit (TCM, Serum) | 42400-2 | 5 x 96-well plates |
| DIY Mouse IFN-Lambda 2/3 (IL-28A/B) ELISA (TCM) | 62830-1 | Materials for 15 x 96-wells |
| Pig IFN-Alpha ELISA Kit (Serum, Plasma, TCM) | 47100-1 | 1 x 96-well plate |
| Cynomolgus IFN-Beta ELISA Kit (Serum, Plasma, TCM) | 46415-1 | 1 x 96-well plate |
| Cynomolgus/Rhesus IFN-Alpha ELISA Kit (Serum, Plasma, TCM) | 46100-1 | 1 x 96-well plate |
| Human IL-22 ELISA, High Sensitivity (Serum, Plasma, TCM) | 41701-1 | 1 x 96-well plate |
| Total Human IL-15 ELISA Kit, High Sensitivity (Serum, Plasma, TCM) | 41702-1 | 1 x 96-well plate |
| Proteins产品列表 |
| 品名 | 货号 | 规格 |
| Human IFN-Lambda 2, Human Cell Expressed | 11720-1 | ≥ 1 x 10⁵ units |
| Human IFN-Lambda 3, Human Cell Expressed | 11730-1 | ≥ 1 x 10⁵ units |
| Human IFN-Lambda 1, Human Cell Expressed | 11725-1 | ≥ 1 x 10⁵ units |
| Human Erythropoietin (EPO), Ultrapure | 11965-1 | 500 units |
| Human Interleukin 22 (Human Cell-Expressed) | 11701-1 | 10 μg |
| Human Interleukin 22 (Human Cell-Expressed) | 11701-2 | 50 μg |
| Human Interleukin 15 / IL-15Rα Heterodimer (Human Cell-Expressed) | 11702-1 | 10 μg |
| Human Interleukin 15 / IL-15Rα Heterodimer (Human Cell-Expressed) | 11702-2 | 50 μg |
| Mouse Interferon Alpha All-Subtype Neutralizing Viral Protein | 12185-1 | 10 μg |
| Mouse Interferon Alpha All-Subtype Neutralizing Viral Protein | 12185-2 | 100 μg |
| UniversalTM Type I IFN (Human IFN-Alpha Hybrid Protein) | 11200-1 | 1 x 10⁵ units |
| UniversalTM Type I IFN (Human IFN-Alpha Hybrid Protein) | 11200-2 | 1 x 10⁶ units |
| Human IFN-Beta 1a, mammalian, carrier-free | 11410-2 | 1 x 10⁶ units |
| Human IFN-Beta (Beta 1a, Mammalian Expressed) | 11415-1 | 1 x 10⁵ units |
| Human IFN-Alpha Sampler Set | 11002-1 | 1 x 10⁵ units |
| Human IFN-Alpha 2a (Alpha A) Protein | 11100-1 | 5 x 10⁶ units |
| Human IFN-Alpha 2a (Alpha A) Protein, Carrier-Free | 11101-1 | 5 μg |
| Human IFN-Alpha 2a (Alpha A) Protein, Carrier-Free | 11101-2 | 20 μg |
| Human IFN-Alpha 2b (Alpha 2) Protein | 11105-1 | 1 x 10⁵ units |
| Human IFN-Alpha 8 (Alpha B2) Protein | 11115-1 | 1 x 10⁵ units |
| Human IFN-Alpha 10 (Alpha C) Protein | 11120-1 | 1 x 10⁵ units |
| Human IFN-Alpha 1 (Alpha D) Protein | 11125-1 | 1 x 10⁵ units |
| Human IFN-Alpha 21 (Alpha F) Protein | 11130-1 | 1 x 10⁵ units |
| Human IFN-Alpha 5 (Alpha G) Protein | 11135-1 | 1 x 10⁵ units |
| Human IFN-Alpha 14 (Alpha H2) Protein | 11145-1 | 1 x 10⁵ units |
| Human IFN-Alpha 17 (Alpha I) Protein | 11150-1 | 1 x 10⁵ units |
| Human IFN-Alpha 7 (Alpha J1) | 11160-1 | 1 x 10⁵ units |
| Human IFN-Alpha 6 (Alpha K) Protein | 11165-1 | 1 x 10⁵ units |
| Human IFN-Alpha D (Alpha 1) Protein | 11175-1 | 1 x 10⁵ units |
| Human IFN-Alpha 4a (Alpha M1) Protein | 11177-1 | 1 x 10⁵ units |
| Human IFN-Alpha 4b (Alpha 4) Protein | 11180-1 | 1 x 10⁵ units |
| Human IFN-Alpha 16 (Alpha WA) Protein | 11190-1 | 1 x 10⁵ units |
| Human IFN-Omega | 11395-1 | 25 μg |
| Human IFN-Beta 1b, E.Coli | 11420-1 | 1 x 10⁵ units |
| Human IL-28A/IFN-Lambda 2, Carrier-Free | 11821-1 | 25 μg |
| Human IL-29/IFN-Lambda 1, Carrier-Free | 11826-1 | 25 μg |
| Human IFN-Gamma | 11500-1 | 50 μg |
| Human IFN-Gamma | 11500-2 | 100 μg |
| Cynomolgus IFN-Alpha 2 (Ile 16), Mammalian | 16105-1 | 1 x 10⁵ units |
| Rhesus/Cynomolgus IFN-Alpha 2 | 14110-1 | 1 x 10⁵ units |
| Feline IFN-Alpha | 15100-1 | 1 x 10⁵ units |
| Porcine IFN-Alpha | 17105-1 | 1 x 10⁵ units |
| Bovine IFN-Tau 2, Mammalian | 19616-1 | 1 x 10⁵ units |
| Mouse IFN-Beta, Mammalian | 12405-1 | 1 x 10⁵ units |
| Mouse IFN-Beta, Mammalian, Carrier-Free | 12410-1 | 1 x 10⁶ units |
| Mouse IFN-Alpha A | 12100-1 | 1 x 10⁵ units |
| Mouse IFN-Alpha 1 | 12105-1 | 1 x 10⁵ units |
| Mouse IFN-Alpha 4, mammalian | 12115-1 | 1 x 10⁵ units |
| Mouse IFN-Alpha 11 | 12125-1 | 1 x 10⁵ units |
| Mouse IFN-Alpha 13 | 12130-1 | 1 x 10⁵ units |
| Mouse IFN-Beta, E.Coli | 12400-1 | 1 x 10⁵ units |
| Mouse IFN-Beta, Carrier-Free | 12401-1 | 1 x 10⁵ units |
| Mouse IL-28B/IFN-Lambda 3 | 12820-1 | 25 μg |
| Mouse IL-28B/IFN-Lambda 3, Carrier-Free | 12821-1 | 25 μg |
| Rat IFN-Alpha 1, Mammalian | 13101-1 | 10 μg |
| Rat IFN-Alpha 14, Mammalian | 13114-1 | 10 μg |
| Rat IFN-Alpha 1 | 13100-1 | 1 x 10⁵ units |
| Rat IFN-Beta | 13400-1 | 1 x 10⁵ units |
| Rat IFN-Gamma | 13500-1 | 10 μg |
| Antibodies产品列表 |
| 品名 | 货号 | 规格 |
| Anti-Human IFN-Alpha, Clone MMHA-2 (MAb) | 21100-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-2 (MAb) | 21100-2 | 500 μg |
| Anti-Human IFN-Alpha, Clone MMHA-1 (MAb) | 21105-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-11 (MAb) | 21112-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-13(MAb) | 21116-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-17 (MAb) | 21118-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-6 (MAb) | 21125-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-9 (MAb) | 21127-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-14 (MAb) | 21129-1 | 50 μg |
| Anti-Human IFN-Alpha, Clone MMHA-8 (MAb) | 21110-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-3 (MAb) | 21400-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-1 (MAb) | 21405-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-2 (MAb) | 21410-1 | 500 μg |
| Anti-Human IFN-Beta, Clone MMHB-12 (MAb) | 21450-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-13 (MAb) | 21455-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-14 (MAb) | 21460-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-15 (MAb) | 21465-1 | 50 μg |
| Anti-Human IFN-Beta, Clone MMHB-16 (MAb) | 21470-1 | 50 μg |
| Anti-Human IFN-Alpha/Beta Receptor 1 Antibody, Clone MMHAR-3 | 21370-1 | 50 μg |
| Anti-Human IFN-Alpha/Beta Receptor Chain 2, Clone MMHAR-2 (MAb) | 21385-1 | 50 μg |
| Anti-Human IFN-Gamma Receptor Chain 2, Clone MMHGR-2 (MAb) | 21585-1 | 250 μg |
| Anti-Human IFN-Lambda Receptor 1, Clone MMHLR-1 (MAb) | 21885-1 | 50 μg |
| Anti-Human IFN-Lambda Receptor 1, Clone HLR14 (MAb) | 21886-1 | 50 μg |
| Anti-Human IFN-Gamma, Clone MMHG-1 (MAb) | 21500-1 | 500 μg |
| Anti-Human IFN-Gamma, Clone MMHG-2 (MAb) | 21550-1 | 100 μg |
| Anti-Human IFN-Gamma Receptor Chain 2, Clone MMHGR-2 (MAb) | 21585-1 | 250 μg |
| Anti-Human IL-28A/IFNL2, neutralizing, Clone MMHL-2 (MAb) | 21720-1 | 200 μg |
| Anti-Human Interleukin-28B/Interferon Lambda 3, neutralizing, Clone MMHL-3 (MAb) | 21730-1 | 100 μg |
| Anti-Human ISG15, Clone 2.1 (MAb) | 21900-1 | 100 μg |
| Anti-Mouse IFN-Alpha, Clone RMMA-1 (MAb) | 22100-1 | 250 μg |
| FITC Conjugated Anti-Mouse IFN-Alpha, Clone RMMA-1 (MAb) | 22100-3 | 25 μg |
| Anti-Mouse IFN-Beta, Clone RMMB-1 (MAb) | 22400-1 | 250 μg |
| Anti-Mouse IFN-Gamma, Clone RMMG-1 (MAb) | 22500-1 | 500 μg |
| Anti-Pig IFN-Alpha, Clone K9 (MAb) | 27100-1 | 500 μg |
| Anti-Pig IFN-Alpha, Clone F17 (MAb) | 27105-1 | 500 μg |
| FITC Conjugated Anti-Mouse IFN-Alpha, Clone RMMA-1 (MAb) | 22100-3 | 25 μg |
| Anti-Human IFN-Alpha, Rabbit Serum (PAb) | 31101-1 | 1 x 10⁵ units |
| Anti-Human IFN-Alpha, Sheep Serum (PAb) | 31110-1 | 1 x 10⁵ units |
| Anti-Human IFN-Alpha (All Subtypes), Rabbit Serum (PAb) | 31135-1 | 1 x 10⁵ units |
| Anti-Human IFN-Beta, Sheep Serum (PAb) | 31401-1 | 2 x 10⁴ units |
| Anti-Human IFN-Beta, Rabbit IgG, protein A purified (PAb) | 31405-1 | 2 x 10⁴ units |
| Anti-Human IFN-Beta, Rabbit Serum (PAb) | 31410-1 | 2 x 10⁴ units |
| Anti-Human IFN-Beta, Goat IgG, Affinity Purified (PAb) | 31420-1 | 100 μg |
| Anti-Human IFN-Gamma, Rabbit Serum (PAb) | 31500-1 | 2 x 10⁴ units |
| Human Type I IFN Neutralizing Antibody Mixture | 39000-1 | 0.2 ml |
| Anti-Mouse IFN-Alpha, Rabbit Serum (PAb) | 32100-1 | 2 x 10⁴ units |
| Anti-Mouse IFN-Alpha, Chicken IgY, Purified (PAb) | 32120-1 | 500 μg |
| Anti-Mouse IFN-Beta, Rabbit Serum (PAb) | 32400-1 | 2 x 10⁴ units |
| Anti-Mouse IFN-Beta, Rabbit IgG, Protein A purified (PAb) | 32401-1 | 2 x 10⁴ units |
| Anti-Mouse IFN-Gamma, Rabbit Serum (PAb) | 32500-1 | 2 x 10⁴ units |
| Anti-Rat IFN-Alpha, Rabbit IgG, Protein A Purified (PAb) | 33100-1 | 500 μg |
| Anti-Rat IFN-Beta, Rabbit IgG, Protein A purified (PAb) | 33400-1 | 500 μg |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技特约代理Biogems产品。
BioGems意为生物钻石,其产品涵盖多种荧光标记的流式抗体、具有生物活性的功能性抗体,以及流式细胞术辅助试剂,如溶血剂和破膜剂等。BioGems产品全部在美国生产,目前已拥有超过500种流式试剂和600余种重组蛋白产品。
Through the establishment of joint collaborations with reputable manufacturers of top-quality life-science research products such as PeproTech Inc., BioGems has positioned itself to become a highly competitive source for a wide-range of recombinant protein and flow-cytometry reagents. Currently, our catalog contains more than 600 recombinant proteins and over 500 flow cytometry reagents. To keep up with the rapidly advancing research fronts, BioGems continuously adds new products to its catalog. All of our products are subjected to a thorough and rigorous quality and performance testing to ensure that each and every product meets the highest established standards. Providing our customers with the highest-quality products at affordable prices is our goal. We are confident that the unique business arrangements of BioGems together with our highly skilled and experienced personnel will enable us to achieve this goal.
主要产品分类:
(1)Flow Cytometry
Conjugated Antibodies
SAFIRE Functional Antibodies
Isotype Controls
Custom and Bulk Reagents
Purified Antibodies
Buffers and Solutions
(2)Recombinant Proteins
Growth Factors & Cytokines
Animal-Free Cytokines
Chemokines
Neurotrophins
Other Proteins
Anti Cytokine & Chemokine Antibodies
(3)Small Molecules
Receptor Antagonist and Inhibitors
Receptor Agonists and Activators
(4)Pre-Coated Elisa Kits
Human
Mouse
Rat
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioGems"> BioGems
PANAGENE公司成立于2006年,以独有的肽核酸技术,为全世界范围内的客户提供高纯度的肽核酸产品。PNA(peptide nucleic acids,PNA)肽核酸技术,是90年代丹麦科学家发明的一类以多肽骨架取代糖磷酸主链的DNA类似物,即以中性的肽链酰胺2-氨基乙基甘氨酸键取代了DNA中的戊糖磷酸二酯键骨架,其余的与DNA相同,PNA可以通过Watson-Crick碱基配对的形式识别并结合DNA或RNA序列,形成稳定的双螺旋结构。
PANAGENE have been supplying Peptide Nucleic Acid (PNA) worldwide and exclusively since 2006 based on our unique invention of efficient synthesis of PNA with high purity, and nowadays we are possessing the best knowledge on PNA and the largest number of patents on the PNA and its applications in the world.
PANAGENE的主要产品包括:
Custom PNA synthesis
Gamma PNA
PNA FISH probe
PNAs™ miRNA inhibitor
Globin Reduction PNA
Fmoc PNA monomer
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

LKT Labs是一家专注于特殊化学品研究和开发的公司。主要提供:药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料。
LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators.
Originally established in 1989 as a research company doing government grant work with exactly these types of molecules, LKT Labs has a unique understanding of the needs of its customers. Its goal is to provide laboratories around the world with a reliable and diverse source of high purity biochemicals with a particular focus on product quality, availability, and customer support.
LKT Labs产品范围:
Cancer Biology
Cardiovascular
Endocrine Signaling and Immunology
Metabolic and GI Pathology
Microbiology
Natural Products
Neuroscience
Peptides
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LKT Labs"> LKT Labs
Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |

Gentarget拥有超过20年的生物试剂生产经验和超过15年的慢病毒工业应用经验。Gentarget研发出诸如SureTiter Lentiviral system , Optional inducible lentiviral system, Eco instant PCR cloning (Fusion in vivo) method等技术。
Incorporated in 2008, GenTarget provides proprietary bio-reagents and services with an emphasis on Lentivirus and Adenovirus gene delivery technologies, providing Pre-made Lentiviruses and Adenovirus for gene over-expression and knockdown and, and Pre-made mammalian stable cell lines.
With an emphasis on product quality and innovation, we develop and manufacture many proprietary technologies such as the such as SureTiterTM Lentiviral system; LocLightTMLive cell imaging, LoxP GFP/RFP ColorSwtich for CRE reproting system, and EcoTM instant PCR cloning method, as well as wide selection of Signal Transduction Pathway Report Lentivirus product series.
Gentarget的主要产品包括:
Premade Lentivirus
Premade stable cells
Recombinant Adenovirus
Control lentivirus
Premade shRNA lentivirus
microRNA lentivirus
anti miRNA lentivirus
Lentivectors
Ultra titer lentivirus
Reagents for lentivirus
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GenTarget"> GenTarget
英国IDS(Immunodiagnostic Systems Limited)公司成立于1977年。主要擅长于骨代谢系列酶免诊断试剂。现已成为体外诊断试剂行业全球公认的创新者和市场佼佼者。特别在骨疾病和钙吸收功能紊乱(骨质疏松、骨软化、变形性骨炎)辅助诊断和治疗疗效监测工具开发、实际应用方面及上述骨异常基本原理机制研究方面,英国IDS公司以经验丰富而闻名于全球。
IDS provides laboratories worldwide with clinical and research solutions in the field of specialty endocrinology. We aim to enhance laboratory efficiency, improve diagnostic accuracy and enrich diagnostic outcomes for patients.
We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.
Immunodiagnostic Systems的主要产品包括:
IDS-iSYS Multi-Discipline Automated System
Bone Metabolism
Calcium Metabolism
Hypertension
CKD-MBD
Cartilage Markers
Growth
Fertility
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Immunodiagnostic Systems (IDS)"> Immunodiagnostic Systems (IDS)
MP Biomedicals是一家全球性的跨国公司,总部位于美国加利福尼亚州,并在欧洲、亚洲、澳洲、南美洲设有区域总部。公司生产和销售超过55000种产品,作为全球领先的生命科学类产品的供应商,至今已有50多年的历史。能够满足客户对分子生物学、生物化学、细胞生物学等各个学科的研究和应用的需求。"
MP Biomedicals is a worldwide corporation that manufactures and distributes products for the life science, fine chemicals and diagnostics markets. We are dedicated to providing scientists and researchers innovative, quality tools to aid them in their research and quest for scientific excellence.
MP Biomedicals的主要产品包括:
Adsorbents
Antibodies & Immunoreagents
Apoptosis
Biochemicals & Reagents
Culture Media & Reagents
Kits and Assays
Labware & Instruments
Rare & Fine Chemicals
Proteins, Enzymes & Peptides
Radiochemicals
Research Diets
Lab Detergents and Sanitizers
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

OZ Biosciences是一家法国的新兴生物技术公司,其成立宗旨是帮助药物公司研发和生产新型的药物导入系统。研究方向主要集中在生物活性材料导入活体组织新技术的研发,2005年该技术研发获得了突破性进展,已经申请了多项国际专利。
OZ Biosciences公司的创办者是分子导入系统的国际权威,在此领域享有极高的声望。研发目标是建立新一代的核酸、蛋白、多肽和其它生物分子的转染导入系统,为广大科研工作者服务。该公司与许多国际知名企业、大学和科研机构有合作往来。OZ Biosciences公司产品极具特色,主打产品是基于纳米技术和生物技术的基础上发展起来的磁转染试剂,相对常规商业化转染试剂,其转染效率更高。
Since 2003, OZ Biosciences creates, develops and produces innovative molecular delivery systems specialized in transfection and transduction tools, for the worldwide scientific community and pharmaceutical industry. OZ Biosciences is focused on delivery technologies of biomolecules such as DNA, RNA and protein for in vitro and in vivo applications.
These past years, the life sciences have gone through a technological revolution. The progress achieved in genomic, functional genomic and proteomic areas has created fabulous opportunities for better understanding of basic biological processes and for the development of the next generation of medicines.
OZ Biosciences公司主要产品线:
(1)Magnetofection™: a unique gene delivery method for in vitro and in vivo applications.
(2)Lipofection: proprietary biodegradable lipid-based transfection reagents.
(3)Transduction tools: for producing, concentrating, storing and enhancing virus efficiency.
(4)3D transfection: allowing nucleic acid delivery directly into 3D matrix.
(5)Protein delivery systems: including antibody & based on biodegradable lipid nanoparticles.
(6)Cell specific reagents: For specific cells such as neurons and stem cells.
(7)Vaccine Adjuvants: Standard & novel adjuvants for antigenic & genetic immunization
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18771149750
邮箱:sales@amyjet.com
0.3079